ANIP vs XRAY · rev $503.5M vs rev $1.78B
ANI Pharmaceuticals Inc (ANIP) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
ANIP currently screens at market cap $1.41B. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the ANIP and XRAY stock pages for the full models.
Not investment advice.